Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Predawn.

Krakoff IH.

Med Pediatr Oncol. 2000 Aug;35(2):157. No abstract available.

PMID:
10918248
2.

Systemic treatment of cancer.

Krakoff IH.

CA Cancer J Clin. 1996 May-Jun;46(3):134-41.

3.

Phase II study of prolonged oral etoposide in refractory ovarian cancer.

Kavanagh JJ, Tresukosol D, De Leon CG, Edwards CL, Freedman RS, Hord M, Howell E, Lenzi R, Krakoff IH, Kudelka AP.

Int J Gynecol Cancer. 1995 Sep;5(5):351-354.

PMID:
11578503
4.

Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.

Lee JS, Newman RA, Lippman SM, Fossella FV, Calayag M, Raber MN, Krakoff IH, Hong WK.

J Clin Oncol. 1995 Jun;13(6):1501-8.

PMID:
7751898
5.

Retinoic acid and interferon in human cancer: mechanistic and clinical studies.

Moore DM, Kalvakolanu DV, Lippman SM, Kavanagh JJ, Hong WK, Borden EC, Paredes-Espinoza M, Krakoff IH.

Semin Hematol. 1994 Oct;31(4 Suppl 5):31-7. Review.

PMID:
7831583
6.
7.

Phase I trial of droloxifene in patients with metastatic breast cancer.

Buzdar AU, Kau S, Hortobagyi GN, Theriault RL, Booser D, Holmes FA, Walters R, Krakoff IH.

Cancer Chemother Pharmacol. 1994;33(4):313-6.

PMID:
8281625
8.

Health care reform in oncology.

Krakoff IH.

Cancer Invest. 1994;12(2):235-6; discussion 236-7. No abstract available.

PMID:
8131099
9.

Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-alpha.

Kudelka AP, Freedman RS, Edwards CL, Lippman SM, Tornos CS, Krakoff IH, Kavanagh JJ.

Anticancer Drugs. 1993 Jun;4(3):335-7.

PMID:
8358060
10.

Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.

Lee JS, Newman RA, Lippman SM, Huber MH, Minor T, Raber MN, Krakoff IH, Hong WK.

J Clin Oncol. 1993 May;11(5):959-66.

PMID:
8487058
11.

13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.

Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, Massimini G, Holdener EE, Krakoff IH.

J Natl Cancer Inst. 1993 Mar 17;85(6):499-500. No abstract available.

PMID:
8445678
12.
13.

Depletion of patients' plasma tryptophan using tryptophan side-chain oxidase columns.

Ho DH, Covington WP, Wallerstein RO, Hester JP, Lin JR, Brown NS, Newman RA, Krakoff IH, Freireich EJ.

Cancer Invest. 1993;11(3):252-7.

PMID:
8485647
14.

Retinoic acid and interferon combination studies in human cancer.

Lippman SM, Glisson BS, Kavanagh JJ, Lotan R, Hong WK, Paredes-Espinoza M, Hittelman WN, Holdener EE, Krakoff IH.

Eur J Cancer. 1993;29A Suppl 5:S9-13. Review.

PMID:
8260265
15.

A phase II study of merbarone in patients with adenocarcinoma of the pancreas.

Jones DV Jr, Ajani JA, Winn RJ, Daugherty KR, Levin B, Krakoff IH.

Cancer Invest. 1993;11(6):667-9.

PMID:
8221199
16.

Clinical pharmacology of combined oral uracil and ftorafur.

Ho DH, Covington WP, Pazdur R, Brown NS, Kuritani J, Newman RA, Raber MN, Krakoff IH.

Drug Metab Dispos. 1992 Nov-Dec;20(6):936-40.

PMID:
1362949
17.

Isolation of sesbanimide from the seed of Sesbania vesicaria.

Kim HL, Krakoff IH, Newman RA.

Gen Pharmacol. 1992 Jul;23(4):701-3.

PMID:
1397977
18.

Current perspectives on the use of bleomycin. Introduction.

Krakoff IH.

Semin Oncol. 1992 Apr;19(2 Suppl 5):1-2. No abstract available.

PMID:
1384137
19.

13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.

Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, Holdener E, Krakoff IH.

J Natl Cancer Inst. 1992 Feb 19;84(4):241-5.

PMID:
1734085
20.

13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.

Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU, Hong WK.

J Natl Cancer Inst. 1992 Feb 19;84(4):235-41.

PMID:
1734084
21.

Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid).

Kleinerman ES, Raymond AK, Bucana CD, Jaffe N, Harris MB, Krakoff IH, Benjamin R, Fidler IJ.

Cancer Immunol Immunother. 1992;34(4):211-20.

PMID:
1537053
22.

Phase I trial of a 72-h continuous-infusion schedule of fazarabine.

Amato R, Ho D, Schmidt S, Krakoff IH, Raber M.

Cancer Chemother Pharmacol. 1992;30(4):321-4.

PMID:
1379523
23.

Phase I trial of FK973: description of a delayed vascular leak syndrome.

Pazdur R, Ho DH, Daugherty K, Bradner WT, Krakoff IH, Raber MN.

Invest New Drugs. 1991 Nov;9(4):377-82.

PMID:
1804817
24.

Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas.

Ajani JA, Pazdur R, Winn RJ, Abbruzzese JL, Levin B, Belt R, Young J, Patt YZ, Krakoff IH.

Invest New Drugs. 1991 Nov;9(4):369-71.

PMID:
1804816
25.

Cancer chemotherapeutic and biologic agents.

Krakoff IH.

CA Cancer J Clin. 1991 Sep-Oct;41(5):264-78. No abstract available.

26.

Gallium nitrate in the treatment of cancer-related hypercalcemia.

Krakoff IH.

Semin Oncol. 1991 Aug;18(4 Suppl 5):3. No abstract available.

PMID:
1925628
27.

Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma.

Ajani JA, Pazdur R, Winn RJ, Abbruzzese JL, Levin B, Wiseman C, Lenado-Lee MA, Patt YZ, Krakoff IH.

Invest New Drugs. 1991 Aug;9(3):257-9.

PMID:
1783525
28.

Phase I studies of trimetrexate using single and weekly dose schedules.

Huan SD, Legha SS, Raber MN, Krakoff IH.

Invest New Drugs. 1991 May;9(2):199-206.

PMID:
1831442
29.

Clinical pharmacology of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) following 72-hour infusion.

Ho DH, Brown N, Lin JR, Covington W, Newman RA, Raber M, Amato R, Schmidt S, Krakoff IH.

Drug Metab Dispos. 1991 May-Jun;19(3):643-7.

PMID:
1717216
30.

Cisplatin nephrotoxicity: diethyldithiocarbamate, WR2721, or just water?

Cvitkovic E, Hayes DM, Golbey RB, Krakoff IH.

J Clin Oncol. 1991 Apr;9(4):707-9. No abstract available.

PMID:
1648600
31.

Cessation of treatment in advanced cancer.

Krakoff IH.

Cancer. 1991 Mar 15;67(6 Suppl):1817-9.

PMID:
1705864
32.

Assessment of pulmonary and hematologic toxicities of liblomycin, a novel bleomycin analog.

Newman RA, Siddik ZH, Travis EL, Followill D, Ayele W, Burditt T, Krakoff IH.

Invest New Drugs. 1990 Feb;8(1):33-41.

PMID:
1693138
33.

Comprehensive criteria for assessing therapy-induced toxicity.

Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH.

Cancer Invest. 1990;8(2):147-59.

PMID:
2400936
34.

Beta-adrenoceptor binding studies with LY195448 and metabolites.

Ho BT, Tansey LW, Engineer MS, Newman RA, Siddik ZH, Field WS, Krakoff IH.

Res Commun Chem Pathol Pharmacol. 1990 Jan;67(1):143-6.

PMID:
2158135
35.

A phase II study of trimetrexate therapy for metastatic colorectal carcinoma.

Ajani JA, Abbruzzese JL, Faintuch JS, Patt YZ, Boman BM, Jackson DE, Levin B, Krakoff IH.

Cancer Invest. 1990;8(6):619-21.

PMID:
2149834
36.

Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.

Abbruzzese JL, Schmidt S, Raber MN, Levy JK, Castellanos AM, Legha SS, Krakoff IH.

Invest New Drugs. 1989 Jul;7(2-3):195-201.

PMID:
2793372
37.

Phase I clinical trial and pharmacokinetic evaluation of 4'-0-tetrahydropyranyladriamycin (THP-adriamycin).

Raber MN, Newman RA, Lu K, Legha S, Gorski C, Benjamin RS, Krakoff IH.

Cancer Chemother Pharmacol. 1989;23(5):311-5.

PMID:
2706737
38.

Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomes.

Khokhar AR, al-Baker S, Krakoff IH, Perez-Soler R.

Cancer Chemother Pharmacol. 1989;23(4):219-24.

PMID:
2647311
39.

The effect of the experimental antitumor agent caracemide on brain choline acetyltransferase.

Ho BT, Tansey LW, Feiffer R, Newman RA, Farquhar D, Fields WS, Krakoff IH.

J Neurosci Res. 1988;19(1):119-21.

PMID:
3343703
40.

Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits.

Ho DH, Wang CY, Lin JR, Brown N, Newman RA, Krakoff IH.

Drug Metab Dispos. 1988 Jan-Feb;16(1):27-9.

PMID:
2894951
41.

Phase I clinical investigation of benzisoquinolinedione.

Legha SS, Ring S, Raber M, Felder TB, Newman RA, Krakoff IH.

Cancer Treat Rep. 1987 Dec;71(12):1165-9.

PMID:
3690526
42.

Clinical pharmacology of trimetrexate.

Ho DH, Covington WP, Legha SS, Newman RA, Krakoff IH.

Clin Pharmacol Ther. 1987 Sep;42(3):351-6.

PMID:
2957140
43.

Inhibition of brain choline acetyltransferase by tetraplatin.

Ho BT, Feiffer R, Tansey LW, Newman RA, Fields WS, Krakoff IH.

Brain Res Bull. 1987 Aug;19(2):283-5.

PMID:
3664284
44.

Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.

Dimery IW, Neidhart JA, McCarthy K, Krakoff IH, Hong WK.

Cancer Treat Rep. 1987 Apr;71(4):425-6. No abstract available.

PMID:
3548960
45.

Cancer chemotherapeutic agents.

Krakoff IH.

CA Cancer J Clin. 1987 Mar-Apr;37(2):93-105. No abstract available.

46.

Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents.

Hacker MP, Khokhar AR, Krakoff IH, Brown DB, McCormack JJ.

Cancer Res. 1986 Dec;46(12 Pt 1):6250-4.

47.

Clinical pharmacology of polyethylene glycol-L-asparaginase.

Ho DH, Brown NS, Yen A, Holmes R, Keating M, Abuchowski A, Newman RA, Krakoff IH.

Drug Metab Dispos. 1986 May-Jun;14(3):349-52.

PMID:
2872037
48.

Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomas.

Ajani JA, Dimery I, Chawla SP, Pinnamaneni K, Benjamin RS, Legha SS, Krakoff IH.

Cancer Treat Rep. 1986 Mar;70(3):375-9.

PMID:
3955548
49.

Phase II study of spirogermanium in patients with advanced colorectal carcinoma.

Ajani JA, Faintuch JS, McClure RK, Levin B, Boman BM, Krakoff IH.

Invest New Drugs. 1986;4(4):383-5.

PMID:
3583645
50.

Clinical and clinical pharmacologic studies of 2-amino-1,3,4-thiadiazole (A-TDA:NSC 4728).

Stewart JA, Ackerly CC, Myers CF, Newman RA, Krakoff IH.

Cancer Chemother Pharmacol. 1986;16(3):287-91.

PMID:
2938841

Supplemental Content

Loading ...
Support Center